The latest news in cancer research, health and policy by Cancer Research UK.
We cover developments in cancer treatments, research into cancer risk and diagnosis as well as the latest cancer science stories. You'll also find analysis and comment on health and cancer policy.
Health Service Policy
The National Institute for Health and Care Excellence (NICE) has approved the drug brentuximab vedotin on the NHS in England.
Around a quarter of GPs have said that urgent referrals for suspected cancer had been turned down by hospitals more often than before the pandemic.
A hormone therapy has been rejected for some adults with newly-diagnosed, advanced prostate cancer.
Cancer services are beginning to get up and running across the country, but we’re still a long way from either restoring capacity or addressing the backlog of people...
A new immunotherapy treatment has been recommended by the National Institute for Health and Care Excellence (NICE) for some adults with small cell lung cancer.
Atezolizumab used in combination with nab-paclitaxel is the first immunotherapy available for triple negative breast cancer.
A new breed of targeted cancer drug has been approved for NHS use in England. But drugs like larotrectinib also pose unique and complex challenges for the NHS, which have...
Cancer services have been severely disrupted across the UK, from screening to treatment and care.
A new combination therapy for adults with an aggressive type of non-Hodgkin lymphoma has not been recommended for NHS use in England.
New ‘chemotherapy-free’ treatment for follicular lymphoma approved for NHS use in England.